Global Neuromodulation Devices Market by Technologies, Geography, Trends and Forecast to 2021

Neuromodulation devices are medical devices used to curb chronic diseases and are used for effective pain management. The devices function by producing electrical impulses to create paraesthesia or numbness in the target area. Neuromodulation device technology is a relatively new concept and is proving to be extremely effective in managing chronic diseases. Neuromodulation includes treatments that involve stimulation or administration of medications directly to the body’s nervous system for therapeutic purposes. The target cells for stimulation include nerves in the central and peripheral nervous system, the autonomic nervous system and the deep cell nuclei of the brain, resulting in modulation of their activity. It can be used to treat movement disorders, spasticity, epilepsy as well as pain syndromes.

Browse Neuromodulation Devices Market by Technology (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/neuromodulation-devices-market/

The global neuromodulation devices market segmentation is based on technology (spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices).

The global neuromodulation devices market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global global neuromodulation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global neuromodulation devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global neuromodulation devices market and included in this report are Boston Scientific Group, Cyberonics, Nevro, Medtronic, Neuronetics Inc., St. Jude Medical, and Uroplasty.

1. Technology
1.1 Spinal Cord Stimulation Devices
1.2 Deep Brain Stimulation Devices
1.3 Sacral Nerve Stimulation Devices
1.4 Vagus Nerve Stimulation Devices
1.5 Gastric Electric Stimulation Devices

2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Boston Scientific
3.2 Cyberonics
3.3 Medtronics
3.4 Nervo
3.5 Neurotics, Inc.
3.6 St. Jude Medical
3.7 Uroplasty

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/neuromodulation-devices-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.